These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36208441)

  • 21. An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications.
    Karanam NK; Story MD
    Int J Radiat Biol; 2021; 97(8):1044-1054. PubMed ID: 33086019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.
    Pohling C; Nguyen H; Chang E; Schubert KE; Nie Y; Bashkirov V; Yamamoto V; Zeng Y; Stupp R; Schulte RW; Patel CB
    Bioelectrochemistry; 2023 Feb; 149():108287. PubMed ID: 36306728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Compatibility of Electric Tumor Treating Fields with Key Anti-tumoral T-Cell Functions.
    Simchony H; Diamant D; Ram Z; Volovitz I
    Isr Med Assoc J; 2019 Jul; 21(7):503. PubMed ID: 31507132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell Imaging.
    Le HT; Staelens M; Lazzari D; Chan G; Tuszyński JA
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
    Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
    Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields).
    Porat Y; Giladi M; Schneiderman RS; Blat R; Shteingauz A; Zeevi E; Munster M; Voloshin T; Kaynan N; Tal O; Kirson ED; Weinberg U; Palti Y
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.
    Jones AB; Schanel TL; Rigsby MR; Griguer CE; McFarland BC; Anderson JC; Willey CD; Hjelmeland AB
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.
    Giladi M; Munster M; Schneiderman RS; Voloshin T; Porat Y; Blat R; Zielinska-Chomej K; Hååg P; Bomzon Z; Kirson ED; Weinberg U; Viktorsson K; Lewensohn R; Palti Y
    Radiat Oncol; 2017 Dec; 12(1):206. PubMed ID: 29284495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing an In Vitro 3D Spheroid Model to Study Medulloblastoma Drug Response and Tumor Dissemination.
    Roper SJ; Coyle B
    Curr Protoc; 2022 Jan; 2(1):e357. PubMed ID: 35080813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
    Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A
    PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential use of CXCL12/CXCR4 and sonic hedgehog pathways as therapeutic targets in medulloblastoma.
    Amarante MK; Vitiello GAF; Rosa MH; Mancilla IA; Watanabe MAE
    Acta Oncol; 2018 Sep; 57(9):1134-1142. PubMed ID: 29771176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
    Wang Y; Pandey M; Ballo MT
    Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.
    Mrugala MM; Shi W; Iwomoto F; Lukas RV; Palmer JD; Suh JH; Glas M
    J Neurooncol; 2024 Aug; 169(1):25-38. PubMed ID: 38949692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
    Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
    Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of tumor treating fields for malignant brain tumors.
    Zhou Y; Xing X; Zhou J; Jiang H; Cen P; Jin C; Zhong Y; Zhou R; Wang J; Tian M; Zhang H
    Cancer Rep (Hoboken); 2023 May; 6(5):e1813. PubMed ID: 36987739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.
    Tanzhu G; Chen L; Xiao G; Shi W; Peng H; Chen D; Zhou R
    Cell Death Discov; 2022 Oct; 8(1):416. PubMed ID: 36220835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors.
    Branter J; Estevez-Cebrero M; Diksin M; Griffin M; Castellanos-Uribe M; May S; Rahman R; Grundy R; Basu S; Smith S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]).
    Shams S; Patel CB
    J Mol Cell Biol; 2022 Dec; 14(8):. PubMed ID: 35973687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor treating fields in cancer treatment in Denmark].
    Korshøj AR; Lukacova S; Mikic N; Cortnum SOS; Lassen-Ramshad Y; Guldberg TL; Severinsen KE; Thielscher A; Poulsen FR; Sørensen JCH; Oettingen GBV
    Ugeskr Laeger; 2019 Oct; 181(20A):. PubMed ID: 31610842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor treating fields in cancer treatment in Denmark].
    Korshøj AR; Lukacova S; Mikic N; Stigaard Cortnum SO; Lassen-Ramshad Y; Guldberg TL; Severinsen KE; Thielscher A; Poulsen FR; Hedemann Sørensen JC; von Oettingen GB
    Ugeskr Laeger; 2019 Jan; 181(5):. PubMed ID: 30722819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.